Similar companies
| Company | Stocktwits Subscribers | |
|---|---|---|
 |
AmgenAMGN |
15,008 0% |
 |
Gilead SciencesGILD |
77,595 0% |
 |
Catalyst PharmaceuticalsCPRX |
15,493 0% |
 |
Inovio PharmaceuticalsINO |
92,245 0% |
 |
Anavex Life SciencesAVXL |
23,923 0% |
NeuroSense Therapeutics Stocktwits Subscriber Count
NeuroSense Therapeutics (NRSN) has 3,543 subscribers on Stocktwits, roughly flat (-0.1%) over the past three months.
With 3,543 subscribers, NeuroSense Therapeutics has a smaller Stocktwits following than Amgen (15,008) and Gilead Sciences (77,595).
Unlike daily Stocktwits mentions, which spike around news and earnings, subscriber count reflects sustained, long-term interest from the retail investor community.
How NRSN’s Stocktwits Community Feeds the AI Score
Stocktwits subscriber count is a direct read on the size of the retail investor community tracking NRSN. It is not a stock price on its own, but sustained growth in subscribers can reflect building retail interest. AltIndex feeds NeuroSense Therapeutics’s Stocktwits community into the NRSN AI Score as one of 25+ alternative data signals, weighed against sentiment, Reddit activity, and fundamentals.
For daily discussion volume, see NRSN Stocktwits mentions. For other retail-community metrics, see Reddit subscribers and Reddit mentions.
Month over Month
| Sep 2026 | 3,536 | |
| Aug 2026 | 3,532 | |
| Jul 2026 | 3,543 | |
| Jun 2026 | 3,546 | |
| May 2026 | 3,556 |
NeuroSense Therapeutics Stocktwits Subscribers: Frequently Asked Questions
NeuroSense Therapeutics (NRSN) has 3,543 subscribers (4K) on Stocktwits, based on AltIndex’s tracking of the stock’s Stocktwits page.
NeuroSense Therapeutics's Stocktwits subscriber base has been roughly flat (-0.1%) over the past three months. View the trend chart above for the full history.
Stocktwits subscriber count is a proxy for the size of the retail investor community tracking a stock. Unlike daily mentions, which spike around news, subscriber growth reflects sustained interest. No single data point predicts a stock on its own, which is why AltIndex combines NRSN’s Stocktwits community with sentiment, Reddit activity, and 20+ other signals in its AI Score rather than reading any one signal in isolation.
NeuroSense Therapeutics underperforms its industry peers when it comes to Stocktwits Subscribers, ranking in the 2nd percentile.
StockTwits is a social media platform designed specifically for the investing community. It enables investors and traders to share market insights, strategies, and real-time news updates. Essentially, it's a specialized network for financial market discussions, often characterized by brief, tweet-like posts.
Sign up and get more insights on NeuroSense Therapeutics.
See NeuroSense Therapeutics’s complete stocktwits subscribers history
Sign up to unlock 1-year and all-time charts for NRSN, plus 25+ alternative data signals, AI Scores, and real-time alerts.
Get Started for FREE
